Developing More Predictive In Vitro Models 3rd Annual Summit

Cutting Edge Advancements in In Vitro Models to Mitigate Toxicity, Streamline Drug Development and Direct Clinical Strategy
25 – 27 September 2012 | Boston
.

Michael Aleo

Michael Aleo:

Michael Aleo completed post-doctoral training as an NIH National Research Service Award Fellow at the University of Georgia after receiving a Ph.D. in Pharmacology and Experimental Therapeutics from The State University of New York at Buffalo.  As a Pfizer research fellow Pfizer, he investigates biochemical mechanisms of drug-induced toxicity.  Michael has received two Pfizer Achievement Awards and currently co-chairs the Pfizer Hepatic Injury Council.  Michael has served on the editorial board of Toxicology and Applied Pharmacology and In Vitro Toxicology and is a full member of the Society of Toxicology where he is a contributing member to several specialty sections.